Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Spectrum Pharmaceuticals: BIOCOM Conference

|Includes: Spectrum Pharmaceuticals, Inc. (SPPI)
Spectrum Pharmaceuticals (NASDAQ:SPPI) presentation at the BIOCOM Conference yesterday is worth listening.



From my view, it seems like SPPI's CEO Raj had a positive outlook for Zevalin's potential with respect to future sales. 

I like what I heard and will remain invested in the company over the long-term.

I hedge long positions with put options.



Disclosure: Long SPPI.